Drug Search Results
More Filters [+]

Cystine

Alternative Names: cystine
Latest Update: 2024-05-11
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Cystine Amino Acid precusor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Australia | Austria | Brazil | Chile | China | Egypt | France | Hong Kong | India | Indonesia | Italy | Korea | Lebanon | Luxembourg | Malaysia | Morocco | Portugal | Russia | Serbia | Spain | Taiwan | Tunisia | Turkey | United Arab Emirates | United Kingdom | Uruguay | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: A/Prof Gary Richardson
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cystine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Autism Spectrum Disorder

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

01291001F

P2

Completed

Autism Spectrum Disorder

2016-10-01

Recent News Events